Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy

RJ Klement, RA Sweeney - Cancer and Metastasis Reviews, 2023 - Springer
Over the past two decades, it has been established that cancer patients with
oligometastases, ie, only a few detectable metastases confined to one or a few organs, may …

Influences on PET quantification and interpretation

JMM Rogasch, F Hofheinz, L van Heek, CA Voltin… - Diagnostics, 2022 - mdpi.com
Various factors have been identified that influence quantitative accuracy and image
interpretation in positron emission tomography (PET). Through the continuous introduction …

18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival

G Polverari, F Ceci, V Bertaglia, ML Reale, O Rampado… - Cancers, 2020 - mdpi.com
Objectives:(1.1) to evaluate the association between baseline 18F-FDG PET/CT semi-
quantitative parameters of the primary lesion with progression free survival (PFS), overall …

Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (NSCLC): a real world experience

L Monaco, M Gemelli, I Gotuzzo, M Bauckneht… - Cancers, 2021 - mdpi.com
Simple Summary The advent of immune-checkpoint inhibitors (ICIs) has significantly
changed the management of patients with non-small cell lung cancer (NSCLC). Although …

PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer

X Wu, Y Huang, Q Zhao, L Wang, X Song, Y Li… - EJNMMI research, 2020 - Springer
Background Immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-
L1) has shown promising results in non-small cell lung cancer (NSCLC) patients. Exploring …

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors

Y Zhao, E Khawandanh, S Thomas, S Zhang… - Radiation …, 2020 - Springer
Background For stereotactic body radiotherapy (SBRT) to central (C) and ultracentral (UC)
lung tumors, our provincial practice has been to prioritize organs at risk (OARs) constraints …

PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients

S Pellegrino, R Fonti, A Pulcrano, S Del Vecchio - Diagnostics, 2021 - mdpi.com
Despite the recent advances in lung cancer biology, molecular pathology, and treatment,
this malignancy remains the leading cause of cancer-related death worldwide and non …

Prognostic value of 18F-FDG PET/CT metabolic parameters in surgically treated stage I lung adenocarcinoma patients

D Tosi, S Pieropan, M Cattoni, G Bonitta… - Clinical Nuclear …, 2021 - journals.lww.com
Results Our main finding was the significant correlation between 18 F-FDG PET/CT
parameters (SUV mean, SUV max, and TLG) and disease-free survival in pathologic stage I …

18F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma and correlation with clinical and genetic findings

X Wu, Y Huang, Y Li, Q Wang, H Wang… - Annals of Nuclear …, 2019 - Springer
Objective Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small-cell lung
cancer with poor prognosis. This study analyzed 18 F-FDG PET/CT in PSC and possible …

Influencing Factors and Prognostic Value of 18F-FDG PET/CT Metabolic and Volumetric Parameters in Non-Small Cell Lung Cancer

L Zhang, Z Ren, C Xu, Q Li, J Chen - International Journal of …, 2021 - Taylor & Francis
Objective This study aims to explore factors influencing metabolic and volumetric
parameters of [18F] fluorodeoxyglucose positron emission tomography/computed …